Glaukos GKOS 深 沪
等待开盘 09-16 09:30:00 美东时间
171.68
+0.590
+0.34%
华盛通- 最 高172.76
- 今 开169.75
- 成交量 62.17万股
- 最 低 167.97
- 昨 收 171.09
- 总市值 101.26亿
- 52周最高 191.62
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 73.16
- 委 比 -51.46%
- 总股本 5898.39万
- 历史最高 191.62
- 量 比 0.74
- 振 幅 2.80%
- 历史最低 14.25
- 每 手 1
- 风险率 29.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today
Glaukos (NYSE:GKOS) has outperformed the market over the past 10 years by 3.9% on an annualized basis producing an average annual return of 17.45%. Currently, Glaukos has a market capitalization of $10.58 billion. Buying $1000 In GKOS: If an investor had bought $1000 of GKOS stock 10 years ago, it w...
09-11 00:00
Small-cap bears were back. Was IWM the warning sign?
The put-call ratio for the iShares Russell 2000 ETF (IWM) surged to 3.58, with Barchart saying the reading marked the highest level since April 2024. The ratio had climbed sharply in the latest readin...
09-02 23:29
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
Okta To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keefe, Bruyette & Woods raised the price target for Progressive Corp (NYSE:PGR) from $226 to $250. Keefe, Bruy...
08-20 20:19
BTIG Maintains Buy on Glaukos, Raises Price Target to $202
BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $193 to $202.
08-20 18:15
近期医疗器械资讯速览
（来源：中国医药报） 转自：中国医药报 国家药监局发布46项医疗器械行业标准、8款产品进入特别审查程序、4个创新医疗器械获批上市……近期，医疗器械领域的这些动态...
08-20 08:09
美股盘后 | Nordson大升7.45%，BitMine Immersion Technologies大升7.16%
Nordson大升7.45%；BitMine Immersion Technologies大升7.16%；Strategy上升3.99%
08-20 06:10
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
As the Q2 earnings season draws to a close, investors are turning their attention to broader metrics to identify sustainable market leaders. With corporate report cards nearly finalized, assessing yea...
08-17 20:26
财报速睇 | Glaukos 2026财年Q2营收1.86亿美元，同比增长0.0%；归母净利润亏损1.52亿美元，同比亏损缩窄0.0%
华盛资讯8月4日讯，Glaukos公布2026财年Q2业绩，公司Q2营收1.86亿美元，同比增长0.0%，归母净利润亏损1.52亿美元，同比亏损缩窄0.0%。
08-04 03:14
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
